Biologics in General Medicine

  • Wolf-Henning Boehncke
  • Heinfried H. Radeke

Table of contents

  1. Front Matter
    Pages I-XVIII
  2. Introduction: Definition and Classification of Biologics

    1. W. -H. Boehncke, H. H. Radeke
      Pages 1-2
  3. Development and Pre-clinical Pharmacology of Biologics

    1. Front Matter
      Pages 3-3
    2. M. Wiekowski, Ch. E. Antoni
      Pages 5-13
    3. J. Salfeld, H. Kupper
      Pages 14-31
    4. Ch. T. Molta
      Pages 32-41
    5. L. M. M. Keller, C. A. Boswell, D. E. Milenic, E. D. Brady, M. W. Brechbiel
      Pages 50-58
    6. B. Hughes, L. E. Hann
      Pages 59-66
  4. Disease-Specific Applications and Clinical Trials

    1. Front Matter
      Pages 67-67
    2. R. Eming, A. Niedermeier, M. Pfütze, A. Jacobi, M. Hertl
      Pages 69-80
    3. W. A. Myers, W. -H. Boehncke, A. B. Gottlieb
      Pages 81-96
    4. R. Gold, R. Hohlfeld
      Pages 141-146
    5. M. Beyer, Ch. Assaf, W. Sterry
      Pages 147-152
    6. D. Schrama, J. C. Becker
      Pages 153-165
  5. Safety and Perspectives

    1. Front Matter
      Pages 167-167
    2. T. N. C. Wells, S. Schnieper-Samec
      Pages 175-183
  6. Back Matter
    Pages 187-190

About this book


The idea for this book was born during the symposium on biologics organized by ZAFES (Center for Drug Research, Development and Safety at the University of Frankfurt am Main) in September 2005. Highly distinguished researchers special- ing in the field of biologics had gathered together to exchange information on this relatively new subject. Realizing that this symposium was one of the few sources of condensed information on biologics, it became obvious that we had to create a means of informing an interested wider circle of scientists and especially general c- nicians. Therefore, the editors of this book suggested to the researchers at the symposium andalsotoprominent scientists andcliniciansinvolvedinthe developmentand application of biologics as their major field of interest the idea of assembling this compendium. We received an overwhelmingly positive response – thankfully also from the publisher – most being more than willing to support this innovative project with highly relevant chapters on the latest state of the art. As we were eager to fill the information gap with up-to-date knowledge, the project had to be finished within the shortest time possible. To all experienced with editing this was obviously a ch- lengeand we areverythankfultoall thecontributorsthatour timeline hadtobe extended by only a few months. This book represents a collection of the most recent knowledge on biologics written by people who have been active in the field for many years. Wolf-Henning Boehncke Heinfried H. Radeke Contents 1 Introduction: Definition and Classification of Biologics W. -H. Boehncke, H. H. Radeke . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .


Arthritis Monitor biotechnology cancer cancer therapy classification clinical trial dermatology medicine pharmaceutical pharmacology psoriasis rheumatoid arthritis safety therapy

Editors and affiliations

  • Wolf-Henning Boehncke
    • 1
  • Heinfried H. Radeke
    • 2
  1. 1.Department of DermatologyClinic of the Johann-Wolfgang-Goethe-UniversityFrankfurt
  2. 2.Dr.-Hans-Schleussner-Foundation Immune Pharmacology pharmazentrum frankfurt, Bldg. 75, Room 103Johann-Wolfgang-Goethe-UniversityFrankfurt

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 2007
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Medicine
  • Print ISBN 978-3-540-29017-9
  • Online ISBN 978-3-540-29018-6
  • Buy this book on publisher's site